INNOVIMMUNE BIOTHERAPEUTICS, INC.

Basic Information

760 Parkside Avenue, Suite 208
Brooklyn, NY, 11226-1508

Company Profile

n/a

Additional Details

Field Value
DUNS: 032579374
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 4


  1. Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis

    Amount: $2,987,700.00

    DESCRIPTION (provided by applicant): There are unmet medical needs in the limited biologic therapeutics for adults with rheumatoid arthritis [RA] associated with 39.2 billion annual US health care an ...

    SBIR Phase II 2014 Department of Health and Human Services
  2. Safe and Efficacious Oral MIF Inhibitors for Rheumatoid Arthritis Treatment

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): There are high unmet medical needs in the limited biologic therapeutics for 1.0% of adults with rheumatoid arthritis [RA] associated with staggering 39.2 billion ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government